Publications:  Dr Helen Storr

Chatterjee S, Cottrell E, Rose SJ, Mushtaq T, Maharaj AV, Williams J, Savage MO, Metherell LA et al.(2020). GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients. Endocrine Connections vol. 9, (3) 211-222.

Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S, Machado MC, Hanzu FA et al.(2019). Time to diagnosis in Cushing's syndrome: A meta-analysis based on 5367 patients. Journal of Clinical Endocrinology and Metabolism

Borysewicz-Sanczyk H, Sawicka B, Cottrell E, Ladha T, Storr H, Bossowski A (2019). Bloom Syndrome in 7-year-old girl diagnosed with short stature. HORMONE RESEARCH IN PAEDIATRICS. vol. 91, 574-574.

Chatterjee S, Rose SJ, Mushtaq T, Cottrell E, Maharaj AV, Williams J, Savage MO, Metherell LA et al. (2019). GHR transcript heterogeneity may explain the phenotypic variability in patients with homozygous GHR pseudoexon (6 Psi) mutation. HORMONE RESEARCH IN PAEDIATRICS. vol. 91, 111-111.

Tufton N, Shapiro L, Sahdev A, Kumar AV, Martin L, Drake WM, Akker SA, Storr HL(2019). An analysis of surveillance screening for SDHB-related disease in childhood and adolescence. Endocrine Connections vol. 8, (3) 162-172.

Storr HL, Chatterjee S, Metherell LA, Foley C, Rosenfeld RG, Backeljauw PF, Dauber A, Savage MO et al.(2019). Nonclassical GH insensitivity: Characterization of mild abnormalities of GH action. Endocrine Reviews vol. 40, (2) 476-505.

Da Costa AR, Qarin S, Bradshaw TY, Watson D, Prasad R, Barnes MR, Metherell LA, Chapple JP et al. (2018). A Novel Stem Cell Model for the Triple a Syndrome. HORMONE RESEARCH IN PAEDIATRICS. Conference: 57th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) (Athens, Greece) from: 27/09/2018 to: 29/09/2018, vol. 90, 29-29.

Cottrell E, Maharaj A, Chatterjee S, Grandone A, Cirillo G, Miraglia del Giudice E, Metherell LA, Storr HL (2018). A Second Growth Hormone Receptor Pseudoexon Mutation Causing Frameshift and Severe Postnatal Growth Failure. HORMONE RESEARCH IN PAEDIATRICS. Conference: European Society for Paediatric Endocrinology vol. 90, 637-638.

Cottrell E, Chatterjee S, Moore G, Ishida M, Greening J, Wright N, Bossowski A, Deeb A et al. (2018). Patients with GH Insensitivity and IGF-1 Resistance Harbour Copy Number Variants Causing a Silver-Russell-Like Phenotype. HORMONE RESEARCH IN PAEDIATRICS. Conference: European Society for Paediatric Endocrinology vol. 90, 105-105.

Chatterjee S, Shapiro L, Rose SJ, Mushtaq T, Clayton PE, Ten SB, Bhangoo A, Kumbattae U et al.(2018). Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation. European Journal of Endocrinology vol. 178, (5) 481-489.

Prete FP, Abdel-Aziz T, Morkane C, Brain C, Kurzawinski TR, Hindmarsh P, Dattani M, Spoudeas H et al.(2018). Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. British Journal of Surgery vol. 105, (10) 1319-1327.

Marques P, Barry S, Ronaldson A, Ogilvie A, Storr HL, Goadsby PJ, Powell M, Dang MN et al.(2018). Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family. Int J Endocrinol vol. 2018, 8581626-8581626.

Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF, Schubert U et al.(2018). Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells. Cell Reports vol. 22, (5) 1236-1249.

Savage MO, Chatterjee S, Hwa V, Storr HL(2018). Growth hormone insensitivity. Encyclopedia of Endocrine Diseases,

Wilkinson ICE, Martin L, Grossman AB, Monson JP, Akker S, Savage MO, Drake WM, Storr HL (2018). New insights into Low Dose Dexamethasone Suppression Test in paediatric Cushing's Syndrome (CS). HORMONE RESEARCH IN PAEDIATRICS. vol. 90, 131-131.

Wilkinson ICE, Savage MO, Storr HL(2018). Pediatric cushing disease. Encyclopedia of Endocrine Diseases,

Shapiro L, Chatterjee S, Ramadan DG, Davies KM, Savage MO, Metherell LA, Storr HL(2017). Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity. European Journal of Endocrinology vol. 177, (6) 485-501.

Yordanova G, Martin L, Afshar F, Sabin I, Alusi G, Plowman NP, Riddoch F, Evanson J et al.(2017). Long-term outcomes of children treated for Cushing's disease: a single center experience. Pituitary vol. 19, (6) 612-624.

Katugampola H, King PJ, Chatterjee S, Meso M, Duncan AJ, Achermann JC, Guasti L, Ghataore L et al.(2017). Kisspeptin is a novel regulator of human fetal adrenocortical development and function – a finding with important implications for the human feto-placental unit. The Journal of Clinical Endocrinology & Metabolism

Wacharasindhu S, Panamonta O, Shapiro L, Metherell LA, Savage MO, Storr HL(2017). Young Thai sisters with growth hormone insensitivity or Laron syndrome. Asian Biomedicine vol. 11, (2) 167-170.

METHERELL LA, Prasad R, Storr HL, Guasti L, Maharaj A, Meimaridou E, Hadjidemetriou I(2017). Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. Journal of Clinical Investigation

Tufton N, Shapiro L, Srirangalingam U, Richards P, Sahdev A, Kumar AV, McAndrew L, Martin L et al.(2017). Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers. Clinical Endocrinology vol. 86, (2) 286-296.

Alkandari HMA, Al Tararwa A, Al Shallal FM, Al Otaibi SA, Storr H (2017). ACTH SECRETING PITUITARY ADENOMA IN A CHILD WITH ROHHAD SYNDROME. HORMONE RESEARCH IN PAEDIATRICS. vol. 88, 512-512.

Chatterjee S, Shapiro L, Rose S, Mushtaq T, Clayton P, Ten S, Bhangoo APS, Kumbattae U et al. (2017). PHENOTYPIC SPECTRUM AND RESPONSES TO RECOMBINANT HUMAN IGF-I (RHIGF-I) THERAPY IN PATIENTS WITH HOMOZYGOUS GH RECEPTOR PSEUDOEXON DEFECTS. HORMONE RESEARCH IN PAEDIATRICS. vol. 88, 290-290.

METHERELL LA (2016). Mutations in SGPL1, encoding sphingosine-1-phosphate lyase, cause a novel form of primary adrenal insufficiency with steroid resistant nephrotic syndrome. Conference: Society for Endocrinology BES 2016 (Brighton)

Shapiro L, Elahi S, Riddoch F, Perry LA, Martin L, Akker SA, Monson JP, Drake WM et al.(2016). Investigation for Paediatric Cushing's Syndrome Using Twenty-Four-Hour Urinary Free Cortisol Determination. Horm Res Paediatr vol. 86, (1) 21-26.

HOWARD SR, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr H, Metherell LA, Sternberg MJE et al.(2016). IGSF10 mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty. EMBO Molecular Medicine vol. 8, (6) 626-42.

Howard S, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr H, Metherell L, Sternberg M et al. (2016). Role of IGSF10 mutations in self-limited delayed puberty. LANCET. vol. 387, 14-14.

Yordanova G, Iotova V, Zheleva E, Bachvarov C, Bocheva Y, Galcheva S, Enchev Y, Ivanov K et al. (2016). Paediatric Cushing Disease: One Patient's Path to Cure. HORMONE RESEARCH IN PAEDIATRICS. vol. 86, 430-430.

Le Quesne Stabej P, Williams HJ, James C, Tekman M, Stanescu HC, Kleta R, Ocaka L, Lescai F et al.(2016). STAG3 truncating variant as the cause of primary ovarian insufficiency. European Journal of Human Genetics vol. 24, (1) 135-138.

Shapiro L, Savage M, Davies K, Metherell L, Storr H (2016). Whole Exome Sequencing can Identify Defects not Detected by Candidate Gene Sequencing in Patients with Short Stature and Features of Growth Hormone Insensitivity (GHI). HORMONE RESEARCH IN PAEDIATRICS. vol. 86, 47-47.

Storr HL, Prasad R, Temple IK, Metherell LA, Savage MO, Walker JM(2015). Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency. J Endocrinol Invest vol. 38, (4) 407-412.

Bang P, Polak M, Woelfle J, Houchard A(2015). Effectiveness and Safety of rhIGF-1 Therapy in Children: The European Increlex� Growth Forum Database Experience. Hormone Research in Paediatrics vol. 83, (5) 345-357.

Storr HL, Dunkel L, Kowalczyk J, Savage MO, Metherell LA(2015). Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: Diagnostic value of serum IGF1 and height at presentation. European Journal of Endocrinology vol. 172, (2) 151-161.

Storr HL, Savage MO(2015). Management of endocrine disease: Paediatric Cushing's disease. European Journal of Endocrinology vol. 173, (1) R35-R45.

Savage MO, Storr HL(2014). Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing's syndrome. Journal of Pediatric Endocrinology and Metabolism vol. 27, (11-12) 1029-1031.

Prasad R, Chan LF, Hughes CR, Kaski JP, Kowalczyk JC, Savage MO, Peters CJ, Nathwani N et al.(2014). Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab vol. 99, (8) E1556-E1563.

Prasad R, Kowalczyk JC, Meimaridou E, Storr HL, Metherell LA(2014). Oxidative stress and adrenocortical insufficiency. J Endocrinol vol. 221, (3) R63-R73.

Storr HL, Drake WM, Evanson J, Matson M, Berney DM, Grossman AB, Akker SA, Monson JP et al.(2014). Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease. Clinical Endocrinology vol. 80, (2) 270-276.

Storr HL, Drake WM, Evanson J, Matson M, Berney DM, Grossman AB, Akker SA, Monson JP et al.(2014). Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease. Clin Endocrinol (Oxf) vol. 80, (2) 270-276.

Perchard R, Say J, Pitts J, Storr HL, Amin R(2014). Use of continuous glucose monitoring to identify glucose dysregulation in growth hormone insensitivity syndrome. Hormone Research in Paediatrics vol. 82, (6) 394-398.

Prasad R, Metherell LA, Clark AJ, Storr HL(2013). Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology vol. 154, (9) 3209-3218.

Meimaridou E, Prasad R, Kowalczyk JC, Clark AJL, Storr HL, Metherell LA(2013). Genome sequencing reveals mitochondrial thiol systems are essential for antioxidant defence in human adrenal glands. FREE RADICAL BIOLOGY AND MEDICINE vol. 65, S38-S38.

Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL et al.(2013). Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study. Eur J Endocrinol vol. 168, (4) 639-648.

Clayton P, Bonnemaire M, Dutailly P, Maisonobe P, Naudin L, Pham E, Zhang Z, Grupe A et al.(2013). Characterizing short stature by insulin-like growth factor axis status and genetic associations: Results from the prospective, cross-sectional, epidemiogenetic EPIGROW study. Journal of Clinical Endocrinology and Metabolism vol. 98, (6)

Williams F, Hunter S, Bradley L, Chahal HS, STORR HL, Akker SA, Kumar AV, Orme SM et al.(2013). Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation. Journal of Clinical Endocrinology and Metabolism vol. 99, (4) 1122-1131.

Guaraldi F, STORR HL, Ghizzoni L, Ghigo E, Savage MO(2013). Paediatric pituitary adenomas: a decade of change. Hormone Research in Paediatrics: from developmental endocrinology to clinical research vol. 81, (3) 145-155.

Savage MO, Storr HL(2012). Pediatric Cushing's disease: Management Issues. Indian J Endocrinol Metab vol. 16, (Suppl 2) S171-S175.

Prasad R, Clark AJ, Storr HL(2012). Deficiency of ALADIN, the AAAS gene product, renders human adrenal and neuronal cells susceptible to oxidative stress. FREE RADICAL BIOLOGY AND MEDICINE vol. 53, S224-S224.

Korbonits M, Storr H, Kumar AV(2012). Familial pituitary adenomas - who should be tested for AIP mutations?. Clin Endocrinol (Oxf) vol. 77, (3) 351-356.

Clark AJL, Storr HL, Meimaridou E, Metherell AL (2012). Oxidative Stress as a Disease Mechanism in Inherited Adrenal Failure. JOURNAL OF PATHOLOGY. vol. 226,

Clark AJL, STORR HL, Meimaridou E, Metherell LA(2012). Oxidative Stress as a Disease Mechanism in Inherited Adrenal Failure. Journal of Pathology vol. 226,

Hughes CR, STORR HL, Grossman AB, Savage MO(2011). Diagnosis and treatment of paediatric Cushing’s disease. Cushing's Disease, Editors: Swearingen, B, Biller, BMK, Springer

Metherell LA, STORR HL, Savage MO(2011). Genetic defects of the human somatotrophic axis. Oxford Textbook of Endocrinology and Diabetes, Editors: Wass, JAH, Stewart, PM, Oxford University Press

Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas GA, Monson JP, Besser GM, Matson M et al.(2011). Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease. Eur J Endocrinol vol. 164, (5) 667-674.

Prasad R, Johnston LB, Savage MO, Martin L, Perry LA, Storr HL(2011). Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance. J Endocrinol Invest vol. 34, (4) 296-299.

Prasad R, Johnston LB, Savage MO, Martin L, Perry LA, Storr HL(2011). Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance. J Endocrinol Invest vol. 34, (4) 296-299.

Savage MO, Afshar F, Plowman PN, Dias RP, Grossman AB, STORR HL(2011). Special aspects of Cushing's syndrome: Childhood. Cushing's Syndrome: Pathophysiology, Diagnosis and Treatment, Editors: Bronstein, MD, Bronstein, M, Humana Press (London),

Chan LF, Vaidya M, Westphal B, Allgrove J, Martin L, Afshar F, Hindmarsh PC, Savage MO et al.(2011). Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease. Horm Res Paediatr vol. 75, (6) 441-446.

Chan LF, Hughes CR, Allgrove JA, Martin L, Afshar F, Hindmarsh PC, Savage MO, Grossman AB et al. (2010). Use of Intravenous Etomidate in a Child To Control Acute Psychosis Induced by the Hypercortisolemia Secondary to Severe Cushing's Disease. ENDOCRINE REVIEWS. vol. 31,

Dias RP, Kumaran A, Chan LF, Martin L, Afshar F, Matson M, Plowman PN, Monson JP et al.(2010). Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease. Eur J Endocrinol vol. 162, (3) 603-609.

Savage MO, Dias RP, Chan LF, Afshar F, Plowman PN, Matson M, Grossman AB, STORR HL(2010). Diagnosis and Treatment of Cushing’s Disease in Children. Pediatric Neuroendocrinology, Editors: Loche, S, Cappa, M, Ghizzoni, L, Maghnie, M et al., Karger Publishers

Savage MO, Dias RP, Chan LF, Afshar F, Plowman NP, Matson M, Grossman AB, Storr HL(2010). Diagnosis and treatment of Cushing's disease in children. Endocr Dev vol. 17, 134-145.

Storr HL, Metherell LA, Dias R, Savage MO, Rasmussen AK, Clark AJL, Main KM(2010). Familial Isolated Primary Pigmented Nodular Adrenocortical Disease Associated with a Novel Low Penetrance PRKAR1A Gene Splice Site Mutation. HORM RES PAEDIAT vol. 73, (2) 115-119.

Storr HL, Metherell LA, Dias R, Savage MO, Rasmussen AK, Clark AJL, Main KM(2010). Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation. Horm Res Paediatr vol. 73, (2) 115-119.

Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, Huebner A, Clark AJL(2009). Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol vol. 23, (12) 2086-2094.

Savage MO, Storr HL(2009). Growth and body composition at diagnosis and postcure in children with Cushing's syndrome. Pediatric Health vol. 3, (1) 13-18.

Dias RP, Kumaran A, Chan LF, Martin L, Afshar F, Matson M, Plowman PN, Monson JP et al.(2009). Prepubertal Cushing's disease: diagnosis, management and therapeutic outcome. HORM RES vol. 72, 72-72.

Savage MO, Chan LF, Grossman AB, Storr HL(2008). Work-up and management of paediatric Cushing's syndrome. Curr Opin Endocrinol Diabetes Obes vol. 15, (4) 346-351.

Cooray SN, Chan L, Metherell L, STORR HL, Clark AJ(2008). Adrenocorticotropin resistance syndromes. Endocrine developmentD vol. 13, 99-116.

Savage MO, Chan LF, Afshar F, Plowman PN, Grossman AB, Storr HL(2008). Advances in the management of paediatric Cushing's disease. HORM RES vol. 69, (6) 327-333.

Storr H, Alexandraki K, Chan L, Martin L, Monson J, Besser M, Grossman A, Savage M(2008). Comparisons in the epidemiology and diagnostic features between paediatric and adult Cushing's disease. HORM RES vol. 70, 24-25.

Dias R, Chaplin T, Jones J, Hall C, Ston H, Patton M, Savage M, Clark A(2008). Homozygosity mapping of possible genetic locus in small for gestational age siblings with a previously undescribed severe short stature syndrome. HORM RES vol. 70, 110-110.

Doufexis M, Storr HL, King PJ, Clark AJL(2007). Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus. FASEB J vol. 21, (14) 4095-4100.

Chan LF, Storr HL, Grossman AB, Savage MO(2007). Pediatric Cushing's syndrome: Clinical features, diagnosis, and treatment. ARQ BRAS ENDOCRINOL vol. 51, (8) 1261-1271.

Savage MO, STORR HL(2007). Linear Growth in Adrenal Disease. Growth Disorders 2E, Editors: Kelnar, C, Savage, M, Saenger, P, Cowell, C et al., CRC Press

Dupuis CC, Storr HL, Perry LA, Ho JTF, Ahmed L, Ong KK, Dunger DB, Monson JP et al.(2007). Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations. CLIN ENDOCRINOL vol. 66, (6) 838-843.

Storr HL, Chan LF, Grossman AB, Savage MO(2007). Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances. TRENDS ENDOCRIN MET vol. 18, (4) 167-174.

Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO(2007). Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. EUR J ENDOCRINOL vol. 156, (4) 477-482.

Storr HL, Savage MO(2007). Adrenal disorders. Growth Disorders, Second Edition,

Savage MO, Storr HL, Chan LF, Grossman AB(2007). Diagnosis and treatment of pediatric Cushing's disease. Pituitary vol. 10, (4) 365-371.

Peters CJ, Ahmed ML, Storr HL, Davies KM, Martin LJ, Allgrove J, Grossman AB, Savage MO(2007). Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. HORM RES vol. 68, (5) 231-235.

Greening JE, Storr HL, McKenzie SA, Davies KM, Martin L, Grossman AB, Savage MO(2006). Linear growth and body mass index in pediatric patients with Cushing's disease or simple obesity. J ENDOCRINOL INVEST vol. 29, (10) 885-887.

Peters CJ, Storr HL, Grossman AB, Savage MO(2006). The role of corticotrophin-releasing hormone in the diagnosis of Cushing's syndrome. EUROPEAN JOURNAL OF ENDOCRINOLOGY vol. 155, S93-S98.

Camacho-Hübner C, Rose S, Preece MA, Sleevi M, Storr HL, Miraki-Moud F, Minuto F, Frystyk J et al.(2006). Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome. J Clin Endocrinol Metab vol. 91, (4) 1246-1253.

Storr H, Koehler K, Huebner A, Chapple JP, Clark AJL(2006). A candidate interacting protein for the nuclear pore protein ALADIN: a potential pathogenic mechanism for the triple A syndrome. HORM RES vol. 65, 16-16.

Chan L, Storr H, Plowman PN, Perry L, Monson J, Besser GM, Grossman A, Savage M(2006). Anterior pituitary function in the long-term follow-up of five paediatric Cushing's disease patients treated with pituitary radiotherapy. HORM RES vol. 65, 186-186.

Peters CJ, Ahmed ML, Storr HL, Davies K, Martin L, Grossman AB, Allgrove J, Savage MO(2006). Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. HORM RES vol. 65, 117-118.

Grossman AB, SAVAGE MO, Storr HL, Dias R, Isidori AM, Perry LA(2006). The Discriminatory Value of the Low Dose Dexamethasone Suppression Test in Paediatric Cushing’s Syndrome. Hormone Research vol. 65, 159-162.

Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO(2006). The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome. HORM RES vol. 65, (3) 159-162.

CLARK AJL, Storr HL, Priestley JV, Michael GJ(2005). Identification of the sites of expression of triple a syndrome mRNA in the rat using hybridisation. Neuroscience vol. 131, (1) 113-123.

Joshi SM, Hewitt RJD, Storr HL, Rezajooi K, Ellamushi H, Grossman AB, Savage MO, Afshar F(2005). Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center. NEUROSURGERY vol. 57, (2) 281-285.

Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM et al.(2005). Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. EUR J ENDOCRINOL vol. 152, (6) 825-833.

Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB et al.(2005). Final adult height and body mass index after cure of paediatric Cushing's disease. CLIN ENDOCRINOL vol. 62, (4) 466-472.

Scommegna S, Greening JP, Storr HL, Davies KM, Shaw NJ, Monson JP, Grossman AB, Savage MO(2005). Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease. J ENDOCRINOL INVEST vol. 28, (3) 231-235.

Storr HL, Clark AJL, Priestley JV, Michael GJ(2005). Identification of the sites of expression of triple a syndrome mRNA in the rat using in situ hybridisation. NEUROSCIENCE vol. 131, (1) 113-123.

Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI et al.(2004). Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia. CLIN ENDOCRINOL vol. 61, (5) 553-559.

Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO(2004). Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. J CLIN ENDOCR METAB vol. 89, (8) 3818-3820.

Chan LF, Storr HL, Scheimberg I, Perry LA, Banerjee K, Miraki-Moud F, Camacho-Hubner C, Savage MO(2004). Pseudo-precocious puberty caused by a juvenile granulosa cell tumor secreting androstenedione, inhibin and insulin-like growth factor-I. J PEDIATR ENDOCR MET vol. 17, (4) 679-684.

Savage MO, Storr HL, Grossman AB, Krassas GE(2003). Growth and growth hormone secretion in paediatric Cushing's disease. Hormones (Athens) vol. 2, (2) 93-97.

Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB et al.(2003). Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab vol. 88, (1) 34-37.

Storr HL, Barwick TD, Snodgrass GAI, Booy R, Morel Y, Reznek RH, Savage MO(2003). Hyperplasia of adrenal rest tissue causing a retroperitoneal mass in a child with 11 beta-hydroxylase deficiency. HORM RES vol. 60, (2) 99-102.

Storr HL, Savage MO, Clark AJL(2002). Advances in the understanding of the genetic basis of adrenal insufficiency. J Pediatr Endocrinol Metab vol. 15 Suppl 5, 1323-1328.

Holness MJ, STORR HL(1993). Altered interactions between lipogenesis and glycogenesis in liver during fructose feeding. Biochemical Society Transactions vol. 21, Article 2,